Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Completed Phase 3 Trials for Meningococcal Meningitis / Meningitis Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT03077438Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
NCT00474526A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants